TY - JOUR T1 - Technical advances in NK cell-based cellular immunotherapy JF - Cancer Biology and Medicine JO - Cancer Biol Med SP - 647 LP - 654 DO - 10.20892/j.issn.2095-3941.2019.0187 VL - 16 IS - 4 AU - Fang Fang AU - Wei Wang AU - Minhua Chen AU - Zhigang Tian AU - Weihua Xiao Y1 - 2019/11/01 UR - http://www.cancerbiomed.org/content/16/4/647.abstract N2 - Natural killer (NK) cells represent a promising future for tumor immunotherapy because of their unique biological functions and characteristics. This review focuses on technical advances in NK cell-based cellular immunotherapy and summarizes the developments of recent years in cell sources, genetic modification, manufacturing systems, clinical programs, and outcomes. Future prospects and challenges in NK cell immunotherapy are also discussed, including off-the-shelf NK cell exploitation, automatic and closed manufacturing systems, cryopreservation, and therapies involving regulatory checkpoints. ER -